These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8186129)

  • 1. Peritumoral injections of interleukin 2 induce tumour regression in metastatic malignant melanoma.
    Gutwald JG; Groth W; Mahrle G
    Br J Dermatol; 1994 Apr; 130(4):541-2. PubMed ID: 8186129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peritumoral administered IL-2-induced tumor regression in melanoma. Pilot study].
    Gutwald J; Groth W; Mahrle G
    Hautarzt; 1994 Aug; 45(8):536-40. PubMed ID: 7960753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of cutaneous metastatic melanoma with high-dose intralesional interleukin-2 treatment combined with cryosurgery.
    Martinez-Lopez A; Almazan-Fernandez FM; Perez-Lopez I; Aguayo-Carreras P; Salvador-Rodriguez L; Cuenca-Barrales C; Arias-Santiago S
    Dermatol Ther; 2018 Jul; 31(4):e12612. PubMed ID: 29766618
    [No Abstract]   [Full Text] [Related]  

  • 4. [Protocol for optimal therapy of malignant melanoma in the metastatic stage by the Dermatologic Oncology Working Group].
    Hauschild A
    Hautarzt; 1996 Jan; 47(1):67-8. PubMed ID: 8835010
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary experiences of intralesional immunotherapy in cutaneous metastatic melanoma.
    Ridolfi L; Ridolfi R
    Hepatogastroenterology; 2002; 49(44):335-9. PubMed ID: 11995445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in Intralesional Therapy for Metastatic Melanoma.
    Sloot S; Rashid OM; Sarnaik AA; Zager JS
    Cancer Control; 2016 Jan; 23(1):12-20. PubMed ID: 27009452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comment on the contribution by G. Fierlbeck, B. d'Hoedt, W. Stroebel, H. Stutte, O. Bogenschütz and G. Rassner. Intralesional therapy of melanoma metastases with recombinant interferon-beta].
    Kölmel KF; Abel U
    Hautarzt; 1993 May; 44(5):329-30. PubMed ID: 8320124
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot study.
    Reali UM; Martini L; Borgognoni L; Semino C; Pietra G; Chiarugi C; Guastella M; Melioli G
    Melanoma Res; 1998 Feb; 8(1):77-82. PubMed ID: 9508381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-associated macrophages are related to progression in patients with metastatic melanoma following interleukin-2 based immunotherapy.
    Hansen BD; Schmidt H; von der Maase H; Sjoegren P; Agger R; Hokland M
    Acta Oncol; 2006; 45(4):400-5. PubMed ID: 16760175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
    Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
    Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases].
    Loquai C; Nashan D; Metze D; Beiteke U; Rüping KW; Luger TA; Grabbe S
    Hautarzt; 2004 Feb; 55(2):176-81. PubMed ID: 14968329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of murine melanoma growth with a combination of microwave hyperthermia and local injection of interleukin 2.
    Nakayama J; Urabe A; Toyofuku K; Taniguchi S; Hori Y
    Br J Dermatol; 1994 Jun; 130(6):717-24. PubMed ID: 8011496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
    Shi VY; Tran K; Patel F; Leventhal J; Konia T; Fung MA; Wilken R; Garcia MS; Fitzmaurice SD; Joo J; Monjazeb AM; Burrall BA; King B; Martinez S; Christensen SD; Maverakis E
    J Am Acad Dermatol; 2015 Oct; 73(4):645-54. PubMed ID: 26259990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma.
    Green DS; Dalgleish AG; Belonwu N; Fischer MD; Bodman-Smith MD
    Br J Dermatol; 2008 Sep; 159(3):606-14. PubMed ID: 18616776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma.
    Dummer R; Hauschild A; Henseler T; Burg G
    Lancet; 1998 Sep; 352(9131):908-9. PubMed ID: 9743016
    [No Abstract]   [Full Text] [Related]  

  • 17. Intratumoral Interleukin-2 Injections Without Systemic Therapy for Isolated Cutaneous Metastatic Breast Cancer.
    Gorman BG; Jakub JW; Hobday TJ; Brewer JD
    Dermatol Surg; 2021 Aug; 47(8):1119-1121. PubMed ID: 33899801
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interferon therapy in malignant melanoma].
    Stadler R; Garbe C
    Z Hautkr; 1990 May; 65(5):504-7. PubMed ID: 1696048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus therapy of human cancers.
    Sinkovics JG; Horvath JC
    Melanoma Res; 2003 Aug; 13(4):431-2. PubMed ID: 12883372
    [No Abstract]   [Full Text] [Related]  

  • 20. Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream.
    Garcia MS; Ono Y; Martinez SR; Chen SL; Goodarzi H; Phan T; Wehrli LN; Miyamura Y; Fung MA; Maverakis E
    Melanoma Res; 2011 Jun; 21(3):235-43. PubMed ID: 21464773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.